Carnitine is removed from the acyl group by CPT2 (carnitine palmitoyltransferase 2), and the free acyl-CoA can then be used for ATP production
Liraglutide is a daily GLP1 receptor agonist (marketed as Saxenda for weight loss, Victoza for diabetes), while Semaglutide is a weekly GLP1 with generally greater average weight loss in trials
Apply to cuts, scrapes, sunburn
Starting Weight Individuals with higher starting weights may experience larger early changes
Discuss pregnancy plans before treatment
Cardiovascular benefits have been demonstrated in clinical trials for specific GLP-1 receptor agonists, with liraglutide, semaglutide, and dulaglutide showing reductions in major adverse cardiovascular events in patients with established cardiovascular disease or high cardiovascular risk